Journal of Clinical Review & Case Reports(JCRC)
ISSN: 2573-9565 | DOI: 10.33140/JCRC
Impact Factor: 1.823
Researchers and authors can directly submit their manuscript online through this link Online Manuscript Submission.
Tucaresol: A Unique Oral Candidate Drug Ideally Accessible For Treatment of Covid-19 Disease.
Citation
Christopher L Penney, Boulos Zacharie, Jean-Simon Duceppe
Penney, C. L., Zacharie, B., Duceppe, J. S. (2023). Tucaresol: A Unique Oral Candidate Drug Ideally Accessible for Treatment of COVID-19 Disease. Journal of Clinical Review & Case Reports, 8(4), 74-83.